A Study of CD20/CD22 Targeted CAR T-cell Therapy for Relapsed or Refractory Lymphoid Malignancies
Clinical trial NCT04283006 · RECRUITING
Trial details
- NCT number
- NCT04283006
- Sponsor
- He Huang
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-23
- Primary completion
- 2023-05-23
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.